Latest News and Press Releases
Want to stay updated on the latest news?
-
New AI-powered app and biologic wound therapies bring hospital-grade care to homes across Greater Houston. Image by Vital Wound Care HOUSTON, June 03, 2025 (GLOBE NEWSWIRE) -- On May 1, Vital...
-
FRAMINGHAM, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
-
Wound Cleanser Product Market to Surpass US$ 2.24 Billion, Expanding at a 1.4% CAGR by 2034: Fact.MR
Rockville, MD, Sept. 25, 2024 (GLOBE NEWSWIRE) -- According to a new industry report released by Fact.MR, the global wound cleanser product market is estimated at US$ 1.96 billion in 2024 and is...
-
Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound
-
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™...
-
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its...
-
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
-
WINNIPEG, Manitoba, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) is pleased to announce that John Coleman has been...
-
Fiscal year-end AC5 Advanced Wound System update includes Q4 record monthly order volumes, favorable reimbursement decisions and increases in paid claims.
-
WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today...